Browse > Article

Regulation of Inflammatory Cytokine Production by Bee Venom in Rat Chondrocytes  

Kim, Eun-Jung (Department of Physical Therapy, College of Health and Wellfare, Dongshin University)
Kim, Gye-Yeop (Department of Physical Therapy, College of Health and Wellfare, Dongshin University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.25, no.1, 2011 , pp. 132-137 More about this Journal
Abstract
Bee venom acupuncture (BVA), as a kind of herbal acupuncture, involved injecting diluted bee venom into acupoints and is used for pain, osteoarthritis and rheumatoid arthritis patients. BVA is growing in popularity, especially in Korea, and is used primarily for pain relief in many kinds of diseases. However, the effect of bee venom anti-inflammatory related action in lipopolysaccharide (LPS) induced chondrocyte stress have not been reported yet. The aim of this study was to investigate the effect of bee venom of cell viability and inflammatory cytokine in rat articular chondrocyte cultures stimulated with lipopolysaccharide. Inflammation was induced in rat chondrocytes by treatment with $10{\mu}g/m{\ell}$ LPS. The change of cell viability were decreased in chondrocytes after treatment with lipopolysaccharide. The cell viability revealed that BV exerted no significant cytotoxicity in the rat chondrocyte. Bee venom inhibited decreased cell viability in the presence of lipopolysaccharide ($10{\mu}g/m{\ell}$) in a dose dependent manner(0.1, 0.5, 1.0 and $5.0{\mu}g/m{\ell}$) at bee venom(p<0.05). Tumor necrosis factor (TNF)-${\alpha}$ production in the presence of lipopolysaccharide($1{\mu}g/m{\ell}$) was also inhibited in a dose dependent manner (p<0.05 from bee venom $0.1{\mu}g/m{\ell}$). Interleukin (IL)-6 production in the presence of lipopolysaccharide ($10{\mu}g/m{\ell}$) was inhibited as well (p<0.05 at bee venom 0.1, 0.5, 1.0 and $5.0{\mu}g/m{\ell}$, respectively). Our results demonstrate that bee venom was a anti-inflammatory agent of chondrocytes. Bee venom may exert its anti inflammatory effects through inhibition of TNF-${\alpha}$ and IL-6 synthesis, and may then pain relief and reduce the articular destruction.
Keywords
Bee venom; Chondrocyte; Inflammatory cytokine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lee, J.Y., Kang, S.S., Kim, J.H., Bae, C.S., Choi, S.H. Inhibitory effect of whole bee venom in adjuvant-induced arthritis. In Vivo. 19(4):801-805, 2005.
2 Kwon, Y.B., Yoon, S.Y., Kim, H.W., Roh, D.H., Kang, S.Y., Ryu, Y.H., Choi, S.M., Han, H.J., Lee, H.J., Kim, K.W., Beitz, A.J., Lee, J.H. Substantial role of locus coeruleus-noradrenergic activation and capsaicin-insensitive primary afferent fibers in bee venom's anti-inflammatory effect. Neurosci Res. 55(2):197-203, 2006.   DOI   ScienceOn
3 Moon, D.O., Park, S.Y., Lee, K.J., Heo, M.S., Kim, K.C., Kim, M.O., Lee, J.D., Choi, Y.H., Kim, G.Y. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int Immuno-pharmacol. 7(8):1092-1101, 2007.   DOI   ScienceOn
4 Son, D.J., Lee, J.W., Lee, Y.H., Song, H.S., Lee, C.K., Hong, J.T. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 115(2):246-270, 2007.   DOI   ScienceOn
5 Hadjipetrou-Kourounakis, L., Yiangou, M. Bee venom, adjuvant induced disease and interleukin production. J Rheumatol. 15(7):1126-1128, 1988.
6 Lories, R.J., Luyten, F.P. Bone morphogenetic protein signaling and arthritis. Cytokine Growth Factor Rev. 20(5-6):467-473, 2009.   DOI   ScienceOn
7 Bernheim, H.A., Gilbert, T.M., Stitt, J.T.. Prostaglandin E levels in third ventricular cerebrospinal fluid of rabbits during fever and changes in body temperature. J Physiol. 301: 69-78, 1980.
8 Chen, J., Lariviere, W.R. The nociceptive and antinociceptive effects of bee venom injection and therapy: a double-edged sword. Prog Neurobiol. 92(2):151-183, 2010.   DOI   ScienceOn
9 Klooster, A.R., Bernier, S.M. Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte. Arthritis Res Ther. 7(1):127-138, 2005.   DOI
10 Cunha, J.M., Cunha, F.Q., Poole, S., Ferreira, S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol. 30(6): 1418-1424, 2000.
11 Son, D.J., Lee, J.W., Lee, Y.H., Song, H.S., Lee, C.K., Hong, J.T. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 115(2):246-270, 2007.   DOI   ScienceOn
12 Niissalo, S., Hukkanen, M., Imai, S., Tornwall, J., Konttinen, Y.T. Neuropeptides in experimental and degenerative arthritis. Ann N Y Acad Sci. 966: 384-399, 2002.   DOI   ScienceOn
13 Kiepe, D., Andress, D.L., Mohan, S., Standker, L., Ulinski, T., Himmele, R., Mehls O., Tönshoff, B. Intact IGF-binding protein-4 and -5 and their respective fragments isolated from chronic renal failure serum differentially modulate IGF-I actions in cultured growth plate chondrocytes. J Am Soc Nephrol. 12(11):2400-2410, 2001.
14 Denizot, F., Lang, R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 22;89(2):271-277, 1986.   DOI   ScienceOn
15 Gill, S.E., Bonnet, C.S., Suri, S., Wilson, D., Walsh, D.A. Neurovascular invasion at the osteochondral junction in osteoarthritis. Ann Rheum Dis. 66(11):1423-1428, 2007.   DOI   ScienceOn
16 Conrozier, T., Chappuis-Cellier, C., Richard, M., Mathieu, P., Richard, S., Vignon, E. Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis. Rev Rhum Engl Ed. 65: 759-765, 1998.
17 Long, L., Soeken, K., Ernst, E. Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology(Oxford). 40(7):779-793, 2001.   DOI
18 Lee, M.S., Pittler, M.H., Shin, B.C., Kong, J.C., Ernst, E. Bee venom acupuncture for musculoskeletal pain: a review. J Pain. 9(4):289-297, 2008.   DOI   ScienceOn
19 Stuhlmeier, K.M. Apis mellifera venom and melittin block neither NF-kappa B-p50-DNA interactions nor the activation of NF-kappa B, instead they activate the transcription of proinflammatory genes and the release of reactive oxygen intermediates. J Immunol. 1;179(1):655-664, 2007.
20 Saad Rached, I.C., Castro, F.M., Guzzo, M.L., de Mello, S.B. Anti-inflammatory effect of bee venom on antigen-induced arthritis in rabbits: influence of endogenous gluco-corticoids. J Ethnopharmacol. 130(1):175-178, 2010.   DOI   ScienceOn
21 Lee, J.D., Park, H.J., Chae, Y., Lim, S. An Overview of bee venom acupuncture in the treatment of arthritis. Evid Based Complement Alternat Med. 2(1):79-84, 2005.   DOI
22 Melchiorri, C., Meliconi, R., Frizziero, L., Silvestri, T., Pulsatelli, L., Mazzetti, I., Borzì, R.M., Uguccioni, M., Facchini, A. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum. 41(12):2165-2174, 1998.   DOI   ScienceOn
23 Pulsatelli, L., Dolzani, P., Piacentini, A., Silvestri, T., Ruggeri, R., Gualtieri, G., Meliconi, R., Facchini, A. Chemokine production by human chondrocytes. J Rheumatol. 26(9):1992-2001, 1999.
24 Kammermann, J.R., Kincaid, S.A., Rumph, P.F., Baird, D.K., Visco, D.M. Tumor necrosis factor-alpha (TNF-alpha) in canine osteoarthritis: Immunolocalization of TNF-alpha, stromelysin and TNF receptors in canine osteoarthritic cartilage. Osteoarthritis Cartilage. 4(1):23-34, 1996.   DOI
25 Felson, D.T. Clinical practice. Osteoarthritis of the knee. N Engl J Med. 23;354(8):841-248, 2006.   DOI   ScienceOn
26 Witter, J., Dionne, R.A. What can chronic arthritis pain teach about developing new analgesic drugs? Arthritis Res Ther. 6(6):279-281, 2004.   DOI
27 Goldring, M.B., Goldring, S.R. Osteoarthritis. J Cell Physiol. 213(3):626-634, 2007.   DOI   ScienceOn
28 Garnero, P., Delmas, P.D. Biomarkers in osteoarthritis. Curr Opin Rheumatol. 15(5):641-646, 2003.   DOI   ScienceOn
29 Hochberg, M.C. Nutritional supplements for knee osteoarthritis-still no resolution. N Engl J Med. 354(8):858- 860, 2006.   DOI   ScienceOn
30 Brooks P. Inflammation as an important feature of osteoarthritis. Bull World Health Organ. 81(9):689-690, 2003.
31 Peyron, J.G. Epidemiologic and etiologic approach of osteoarthritis. Semin Arthritis Rheum. 8(4):288-306, 1979.   DOI   ScienceOn
32 Leveille, S.G., Ling, S., Hochberg, M.C., Resnick, H.E., Bandeen-Roche, K.J., Won, A., Guralnik, J.M. Widespread musculoskeletal pain and the progression of disability in older disabled women. Ann Intern Med. 18;135(12):1038-1046, 2001.   DOI   ScienceOn
33 Jordan, K.M., Arden, N.K., Doherty, M., Bannwarth, B., Bijlsma, J.W., Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis, P., Lohmander, S., Leeb, B., Lequesne, M., Mazieres, B., Martin-Mola, E., Pavelka, K., Pendleton, A., Punzi, L., Serni, U., Swoboda, B., Verbruggen, G., Zimmerman-Gorska, I., Dougados, M. Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT). Ann Rheum Dis. 62(12):1145-1155, 2003.   DOI   ScienceOn